Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009.

[1]  N. Guiso.  Bordetella pertussis and pertussis vaccines. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Dore,et al.  First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. , 2009, Vaccine.

[3]  T. Kallonen,et al.  Bordetella pertussis strain variation and evolution postvaccination , 2009, Expert review of vaccines.

[4]  V. Chenal-Francisque,et al.  Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. , 2009, Research in microbiology.

[5]  N. Guiso,et al.  Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas. , 2008, Microbes and infection.

[6]  J. Pennings,et al.  Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strains , 2008, BMC Genomics.

[7]  V. Caro,et al.  Genomic Content of Bordetella pertussis Clinical Isolates Circulating in Areas of Intensive Children Vaccination , 2008, PloS one.

[8]  J. Mertsola,et al.  Factors contributing to pertussis resurgence. , 2008, Future microbiology.

[9]  O. Bjørnstad,et al.  Of mice and men: asymmetric interactions between Bordetella pathogen species , 2008, Parasitology.

[10]  Aaron M. Wendelboe,et al.  Transmission of Bordetella pertussis to Young Infants , 2007, The Pediatric infectious disease journal.

[11]  C. Locht,et al.  Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. , 2006, Microbes and infection.

[12]  J. Mertsola,et al.  Bordetella pertussis, Finland and France , 2006, Emerging infectious diseases.

[13]  F. Mooi,et al.  Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. , 2005, Microbes and infection.

[14]  Seema Mattoo,et al.  Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies , 2005, Clinical Microbiology Reviews.

[15]  Mineo Watanabe,et al.  Whooping cough due to Bordetella parapertussis: an unresolved problem , 2004, Expert review of anti-infective therapy.

[16]  S. Thiberge,et al.  Comparison of the Bordetella pertussis and Bordetella parapertussis Isolates Circulating in Saint Petersburg between 1998 and 2000 with Russian Vaccine Strains , 2003, Journal of Clinical Microbiology.

[17]  S. Halperin,et al.  Pertussis of adults and infants. , 2002, The Lancet. Infectious diseases.

[18]  H. Hallander,et al.  Fimbrial Typing of Bordetella pertussis Isolates: Agglutination with Polyclonal and Monoclonal Antisera , 2001, Journal of Clinical Microbiology.

[19]  F. Mooi,et al.  Epidemiological Typing of Bordetella pertussis Isolates: Recommendations for a Standard Methodology , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[20]  S. Baron,et al.  Influence of vaccination coverage on pertussis transmission in France , 1999, The Lancet.

[21]  J. Cherry,et al.  Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Mertsola,et al.  Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. , 1998, JAMA.

[23]  F. Simondon,et al.  Evaluation of an Immunoglobulin G Enzyme-Linked Immunosorbent Assay for Pertussis Toxin and Filamentous Hemagglutinin in Diagnosis of Pertussis in Senegal , 1998, Clinical Diagnostic Laboratory Immunology.

[24]  S. Mboup,et al.  A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. , 1997, Vaccine.

[25]  N. Guiso,et al.  Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species , 1993, Infection and immunity.

[26]  P. Coursaget,et al.  Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal. , 1991, Vaccine.

[27]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[28]  H. Lautrop.  Epidemics of parapertussis. 20 years' observations in Denmark. , 1971, Lancet.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.